Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

433 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and west.
Dahan S, Segal Y, Watad A, Azrielant S, Shemer A, Maymon D, Stroev YI, Sobolevskaya PA, Korneva EA, Blank M, Gilburd B, Shovman O, Amital H, Ehrenfeld M, Tanay A, Kivity S, Pras E, Chapman J, Damoiseaux J, Cervera R, Putterman C, Shapiro I, Mouthon L, Perricone R, Bizzaro N, Koren O, Riemekasten G, Chereshnev VA, Mazurov VI, Goloviznin M, Gurevich V, Churilov LP, Shoenfeld Y. Dahan S, et al. Among authors: gurevich v. Autoimmun Rev. 2017 Dec;16(12):1175-1184. doi: 10.1016/j.autrev.2017.10.001. Epub 2017 Oct 14. Autoimmun Rev. 2017. PMID: 29037903 Review. No abstract available.
Statins and autoimmune diseases.
Gurevich VS, Shovman O, Slutzky L, Meroni PL, Shoenfeld Y. Gurevich VS, et al. Autoimmun Rev. 2005 Mar;4(3):123-9. doi: 10.1016/j.autrev.2004.08.037. Autoimmun Rev. 2005. PMID: 15823497 Review.
Influenza, autoimmunity and atherogenesis.
Gurevich VS. Gurevich VS. Autoimmun Rev. 2005 Feb;4(2):101-5. doi: 10.1016/j.autrev.2004.10.006. Epub 2004 Nov 20. Autoimmun Rev. 2005. PMID: 15722256 Review.
Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease.
Paraskevas KI, Gloviczki P, Antignani PL, Comerota AJ, Dardik A, Davies AH, Eckstein HH, Faggioli G, Fernandes E Fernandes J, Fraedrich G, Geroulakos G, Golledge J, Gupta A, Gurevich VS, Jawien A, Jezovnik MK, Kakkos SK, Knoflach M, Lanza G, Liapis CD, Loftus IM, Mansilha A, Nicolaides AN, Pini R, Poredos P, Proczka RM, Ricco JB, Rundek T, Saba L, Schlachetzki F, Silvestrini M, Spinelli F, Stilo F, Suri JS, Svetlikov AV, Zeebregts CJ, Chaturvedi S, Veith FJ, Mikhailidis DP. Paraskevas KI, et al. Among authors: gurevich vs. Prog Cardiovasc Dis. 2022 Jul-Aug;73:41-47. doi: 10.1016/j.pcad.2022.05.003. Epub 2022 May 20. Prog Cardiovasc Dis. 2022. PMID: 35605696 Review.
[Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts].
Kobalava JD, Gurevich VS, Galyavich AM, Kaminnyi AI, Kashtalap VV, Mareev VY, Susekov AV, Shaposhnik II. Kobalava JD, et al. Among authors: gurevich vs. Kardiologiia. 2019 Jun 20;59(5S):47-57. doi: 10.18087/cardio.n581. Kardiologiia. 2019. PMID: 31221075 Russian.
Autoimmune nature of influenza atherogenicity.
Gurevich VS, Pleskov VM, Levaya MV. Gurevich VS, et al. Ann N Y Acad Sci. 2005 Jun;1050:410-6. doi: 10.1196/annals.1313.092. Ann N Y Acad Sci. 2005. PMID: 16014558 Review.
Antioxidative activity of high density lipoproteins in vivo.
Klimov AN, Gurevich VS, Nikiforova AA, Shatilina LV, Kuzmin AA, Plavinsky SL, Teryukova NP. Klimov AN, et al. Among authors: gurevich vs. Atherosclerosis. 1993 Apr;100(1):13-8. doi: 10.1016/0021-9150(93)90063-z. Atherosclerosis. 1993. PMID: 8318059
433 results